TheNote.app
Sign In
Sign Up
RSS European Medicines Agency (EMA) | What's new
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 14, Status: Authorised
www.ema.europa.eu
www.ema.europa.eu
